eRAPID electronic patient self-reporting of adverse-events: patient information and advice: a pilot study protocol in pelvic radiotherapy.
Authors
Holch, PPini, S
Henry, A
Davidson, Susan E
Routledge, Jacqueline A
Brown, J
Absolom, K
Gilbert, A
Franks, K
Hulme, C
Morris, C
Velikova, G
Affiliation
Department of Psychology, School of Social Sciences, Leeds Beckett University, Calverley Building, Room CL 815 City Campus, Leeds, LS1 9HE UKIssue Date
2018
Metadata
Show full item recordAbstract
An estimated 17,000 patients are treated annually in the UK with radical radiotherapy (RT) for pelvic cancer. New treatment approaches in RT have increased survivorship and changed the subjective toxicity profile for patients who experience acute and long-term pelvic-related adverse events (AE). Multi-disciplinary follow-up creates difficulty for monitoring and responding to these events during treatment and beyond. Originally developed for use in systemic oncology therapy eRAPID (electronic patient self-Reporting of Adverse-events: Patient Information and aDvice) is an online system for patients to report AEs from home. eRAPID enables patient data to be integrated into the electronic patient records for use in clinical practice, provides patient management advice for mild and moderate AE and advice to contact the hospital for severe AE. The system has now been developed for pelvic RT patients, and we aim to test the intervention in a pilot study with staff and patients to inform a future randomised controlled trial (RCT).Citation
eRAPID electronic patient self-reporting of adverse-events: patient information and advice: a pilot study protocol in pelvic radiotherapy. 2018, 4: 110 Pilot Feasibility StudJournal
Pilot and Feasibility StudiesDOI
10.1186/s40814-018-0304-6PubMed ID
29992040Type
ArticleLanguage
enISSN
2055-5784ae974a485f413a2113503eed53cd6c53
10.1186/s40814-018-0304-6
Scopus Count
Collections
Related articles
- Electronic patient self-Reporting of Adverse-events: Patient Information and aDvice (eRAPID): a randomised controlled trial in systemic cancer treatment.
- Authors: Absolom K, Holch P, Warrington L, Samy F, Hulme C, Hewison J, Morris C, Bamforth L, Conner M, Brown J, Velikova G, eRAPID systemic treatment work group
- Issue date: 2017 May 8
- Online Symptom Monitoring During Pelvic Radiation Therapy: Randomized Pilot Trial of the eRAPID Intervention.
- Authors: Holch P, Absolom KL, Henry AM, Walker K, Gibson A, Hudson E, Rogers Z, Holmes M, Peacock R, Pini S, Gilbert A, Davidson S, Routledge J, Murphy A, Franks K, Hulme C, Hewison J, Morris C, McParland L, Brown J, Velikova G
- Issue date: 2023 Mar 1
- Development of an integrated electronic platform for patient self-report and management of adverse events during cancer treatment.
- Authors: Holch P, Warrington L, Bamforth LCA, Keding A, Ziegler LE, Absolom K, Hector C, Harley C, Johnson O, Hall G, Morris C, Velikova G
- Issue date: 2017 Sep 1
- Phase III Randomized Controlled Trial of eRAPID: eHealth Intervention During Chemotherapy.
- Authors: Absolom K, Warrington L, Hudson E, Hewison J, Morris C, Holch P, Carter R, Gibson A, Holmes M, Clayton B, Rogers Z, McParland L, Conner M, Glidewell L, Woroncow B, Dawkins B, Dickinson S, Hulme C, Brown J, Velikova G
- Issue date: 2021 Mar 1